PD-166793

N/A

Report date: 2024/03/29 11:16:43
NME

Base Information

Drug NamePD-166793
Drug Alias NamePD166793
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase-2Matrix metalloproteinase 3
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A